Bijan Nejadnik

Company: Mitsubishi Tanabe Pharma

Job title: Head of Global Development, Regulatory Affairs & Quality Assurance

Seminars:

Panel Discussion: Striving for Consensus on the Level of Evidence Required for Approval 10:45 am

How can we best reconcile the variance in acceptable measures of ALSFRS-R decline across geographies to get drugs to patients faster? How does the level of evidence required for accelerated approval vary in familial vs sporadic ALS? When are expanded access programs deemed acceptable ahead of final study results? If there’s going to be a…Read more

day: Day Two Track B AM